AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 239 filers reported holding AMICUS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $5,000 | -37.5% | 482 | -43.8% | 0.00% | -50.0% |
Q2 2021 | $8,000 | 0.0% | 857 | +8.8% | 0.00% | 0.0% |
Q1 2021 | $8,000 | -61.9% | 788 | -15.3% | 0.00% | -60.0% |
Q4 2020 | $21,000 | -16.0% | 930 | -46.9% | 0.01% | -28.6% |
Q3 2020 | $25,000 | -3.8% | 1,751 | 0.0% | 0.01% | -22.2% |
Q2 2020 | $26,000 | +62.5% | 1,751 | 0.0% | 0.01% | +50.0% |
Q1 2020 | $16,000 | +33.3% | 1,751 | +46.5% | 0.01% | +100.0% |
Q4 2019 | $12,000 | +1100.0% | 1,195 | +986.4% | 0.00% | – |
Q3 2019 | $1,000 | -93.8% | 110 | -91.4% | 0.00% | -100.0% |
Q2 2019 | $16,000 | – | 1,284 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |